High Prevalence of Impaired Glucose Metabolism Among Children and Adolescents Living with HIV in Ghana

Overview

Journal HIV Med

Publisher Wiley

Specialty Infectious Diseases

Date 2024 Jan 19

PMID 38240173

Authors

Ruth Ayanful-Torgby

Veronika Shabanova

Akosua A Essuman

Emmanuel Boafo

Frank Aboagye

Yusuf Al-Mahroof

Jones Amponsah

John K A Tetteh

Linda E Amoah

Elijah Paintsil

Affiliations

Soon will be listed here.

Abstract

Background: Antiretroviral therapy (ART)-associated metabolic abnormalities, including impairment of glucose metabolism, are prevalent in adults living with HIV. However, the prevalence and pathogenesis of impaired glucose metabolism in children and adolescents living with HIV, particularly in sub-Saharan Africa, are not well characterized. We investigated the prevalence of impaired glucose metabolism among children and adolescents living with perinatally infected HIV in Ghana.

Methods: In this multicentre, cross-sectional study, we recruited participants from 10 paediatric antiretroviral treatment clinics from January to June 2022 in 10 facilities in Greater Accra and Eastern regions of Ghana. We determined impaired glucose metabolism in the study sample by assessing fasting blood sugar (FBS), insulin resistance as defined by the homeostatic model assessment for insulin resistance (HOMA-IR) index and glycated haemoglobin (HbA1c) levels. The prevalence of impaired glucose metabolism using each criterion was stratified by age and sex. The phenotypic correlates of glucose metabolism markers were also assessed among age, sex, body mass index (BMI) and waist-to-hip ratio (WHR).

Results: We analysed data from 393 children and adolescents living with HIV aged 6-18 years. A little over half (205/393 or 52.25%) of the children were female. The mean age of the participants was 11.60 years (SD = 3.50), with 122/393 (31.00%) aged 6-9 years, 207/393 (52.67%) aged 10-15 years, and 62/393 (15.78%) aged 16-18 years. The prevalence rates of glucose impairment in the study population were 15.52% [95% confidence interval (CI): 12.26-19.45], 22.39% (95% CI: 18.54-26.78), and 26.21% (95% CI: 22.10-30.78) using HbA1c, HOMA-IR, and FBS criteria, respectively. Impaired glucose metabolism detected by FBS and HOMA-IR was higher in the older age group, whereas the prevalence of abnormal HbA1c levels was highest among the youngest age group. Age and BMI were positively associated with FBS and HOMA-IR (p < 0.001). However, there was negative correlation of WHR with HOMA-IR (p < 0.01) and HbA1c (p = 0.01).

Conclusion: The high prevalence of impaired glucose metabolism observed among the children and adolescents living with HIV in sub-Saharan Africa is of concern as this could contribute to the development of metabolic syndrome in adulthood.

References

Paganella M, Cohen R, Harris D, de Souza Kuchenbecker R, Sperhacke R, Kato S . Association of Dyslipidemia and Glucose Abnormalities With Antiretroviral Treatment in a Cohort of HIV-Infected Latin American Children. J Acquir Immune Defic Syndr. 2016; 74(1):e1-e8. PMC: 5140693. DOI: 10.1097/QAI.0000000000001163. View

Al-Daghri N, Al-Attas O, Alokail M, Alkharfy K, Wani K, Amer O . Does visceral adiposity index signify early metabolic risk in children and adolescents?: association with insulin resistance, adipokines, and subclinical inflammation. Pediatr Res. 2013; 75(3):459-63. DOI: 10.1038/pr.2013.229. View

Innes S, Abdullah K, Haubrich R, Cotton M, Browne S . High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral Therapy. Pediatr Infect Dis J. 2015; 35(1):e1-7. PMC: 4707556. DOI: 10.1097/INF.0000000000000927. View

Tzur F, Chowers M, Agmon-Levin N, Mekori Y, Hershko A . Increased Prevalence of Diabetes Mellitus in a Non-Obese Adult Population: HIV-Infected Ethiopians. Isr Med Assoc J. 2015; 17(10):620-3. View

Assuncao S, Sorte N, Alves C, Mendes P, Alves C, Silva L . Glucose alteration and insulin resistance in asymptomatic obese children and adolescents. J Pediatr (Rio J). 2017; 94(3):268-272. DOI: 10.1016/j.jped.2017.06.008. View

Rosso R, Parodi A, DAnnunzio G, Ginocchio F, Nicolini L, Torrisi C . Evaluation of insulin resistance in a cohort of HIV-infected youth. Eur J Endocrinol. 2007; 157(5):655-9. DOI: 10.1530/EJE-07-0414. View

Yajnik C, Katre P, Joshi S, Kumaran K, Bhat D, Lubree H . Higher glucose, insulin and insulin resistance (HOMA-IR) in childhood predict adverse cardiovascular risk in early adulthood: the Pune Children's Study. Diabetologia. 2015; 58(7):1626-36. PMC: 4472941. DOI: 10.1007/s00125-015-3602-z. View

Feinstein L, Edmonds A, Chalachala J, Okitolonda V, Lusiama J, Van Rie A . Temporal changes in the outcomes of HIV-exposed infants in Kinshasa, Democratic Republic of Congo during a period of rapidly evolving guidelines for care (2007-2013). AIDS. 2014; 28 Suppl 3:S301-11. PMC: 4600322. DOI: 10.1097/QAD.0000000000000331. View

Geffner M, Patel K, Miller T, Hazra R, Silio M, Van Dyke R . Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study. Horm Res Paediatr. 2011; 76(6):386-91. PMC: 3697231. DOI: 10.1159/000332957. View

10.

Reng S, Uloko E, Puepet H, Onwuegbuzie A, Ramalan A . Prevalence and determinants of glucose intolerance among HIV/AIDS patients in north-central Nigeria. Niger J Med. 2018; 25(2):128-32. View

11.

Noumegni S, Nansseu J, Moor Ama V, Bigna J, Assah F, Guewo-Fokeng M . Insulin resistance and associated factors among HIV-infected patients in sub-Saharan Africa: a cross sectional study from Cameroon. Lipids Health Dis. 2017; 16(1):148. PMC: 5553591. DOI: 10.1186/s12944-017-0543-1. View

12.

Anuurad E, Semrad A, Berglund L . Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease. Metab Syndr Relat Disord. 2009; 7(5):401-10. PMC: 3135885. DOI: 10.1089/met.2008.0096. View

13.

Gillett M . International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327-1334. Clin Biochem Rev. 2009; 30(4):197-200. PMC: 2791773. View

14.

Sinha R, Fisch G, Teague B, Tamborlane W, Banyas B, Allen K . Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002; 346(11):802-10. DOI: 10.1056/NEJMoa012578. View

15.

Dimock D, Thomas V, Cushing A, Purdy J, Worrell C, Kopp J . Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood. Metabolism. 2010; 60(6):874-80. PMC: 3021796. DOI: 10.1016/j.metabol.2010.08.007. View

16.

Trico D, Natali A, Arslanian S, Mari A, Ferrannini E . Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents. JCI Insight. 2018; 3(24). PMC: 6338316. DOI: 10.1172/jci.insight.124912. View

17.

Nathan D, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine R . Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008; 31(8):1473-8. PMC: 2742903. DOI: 10.2337/dc08-0545. View

18.

Frigati L, Jao J, Mahtab S, Agyei N, Cotton M, Myer L . Insulin Resistance in South African Youth Living with Perinatally Acquired HIV Receiving Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2018; 35(1):56-62. PMC: 6343194. DOI: 10.1089/AID.2018.0092. View

19.

Das R, Mangaraj M, Panigrahi S, Satapathy A, Mahapatro S, Ray P . Metabolic Syndrome and Insulin Resistance in Schoolchildren From a Developing Country. Front Nutr. 2020; 7:31. PMC: 7141174. DOI: 10.3389/fnut.2020.00031. View

20.

Chahkandi T, Taheri F, Bijari B, Kazemi T, Namakin K, Zardast M . Prevalence of high normal FBS and prediabetes among adolescents in Birjand, East of Iran, 2012. J Educ Health Promot. 2015; 4:68. PMC: 4579764. DOI: 10.4103/2277-9531.162389. View